Evidence map›Paper›PMID 29307017›Full record

ArticleMetabolic brain disease2018

Clinical characteristics and mutation analysis of five Chinese patients with maple syrup urine disease.

Xiaomei Li, Yali Yang, Qing Gao, Min Gao, Yvqiang Lv, Rui Dong, Yi Liu, Kaihui Zhang, Zhongtao Gai

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaomei LiDepartment of Neonatology, Qilu Children's Hospital of Shandong University, Jinan, Shandong, 250022, China.
Yali YangDepartment of Rehabilitation, Qilu Children's Hospital of Shandong University, Jinan, Shandong, 250022, China.
Qing GaoDepartment of Genetics, Jinan Maternity and Child Care Hospital, Jinan, Shandong, 250001, China.
Min GaoPediatric Research Institute, Qilu Children's Hospital of Shandong University, 23976 Jingshi Road, Jinan, Shandong, 250022, China.
Yvqiang LvPediatric Research Institute, Qilu Children's Hospital of Shandong University, 23976 Jingshi Road, Jinan, Shandong, 250022, China.
Rui DongPediatric Research Institute, Qilu Children's Hospital of Shandong University, 23976 Jingshi Road, Jinan, Shandong, 250022, China.
Yi LiuPediatric Research Institute, Qilu Children's Hospital of Shandong University, 23976 Jingshi Road, Jinan, Shandong, 250022, China.
Kaihui ZhangPediatric Research Institute, Qilu Children's Hospital of Shandong University, 23976 Jingshi Road, Jinan, Shandong, 250022, China. khz83@163.com.
Zhongtao GaiPediatric Research Institute, Qilu Children's Hospital of Shandong University, 23976 Jingshi Road, Jinan, Shandong, 250022, China. gaizhongtao@sina.com.
Qilu Hospital of Shandong University · CNJinan Maternity And Care Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maple syrup urine disease (MSUD) is an autosomal recessive disorder affecting branched-chain amino acids (BCAAs) metabolism and caused by a defect in the thiamine-dependent enzyme branched chain α-ketoacid dehydrogenase (BCKD) with subsequent accumulation of BCAAs and corresponding branched-chain keto acids (BCKAs) metabolites. Presently, at least 4 genes of BCKDHA, BCKDHB, DLD and DBT have been reported to cause MSUD. Furthermore, more than 265 mutations have been identified as the cause across different populations worldwide. Some studies have reported the data of gene mutations in Chinese people with MSUD. In this study, we present clinical characteristics and mutational analyses in five Chinese Han child with MSUD, which had been screened out by tandem mass spectrometry detection of amino acids in blood samples. High-throughput sequencing, Sanger sequence and real-time qualitative PCR were performed to detect and verify the genetic mutations. Six different novel genetic variants were validated in BCKDHB gene and BCKDHA gene, including c.523 T > C, c.659delA, c.550delT, c.863G > A and two gross deletions. Interestingly, 3 cases had identical mutation of BCKDHB gene (c.659delA). We predicted the pathogenicity and analyzed the clinical characteristics. The identification of these mutations in this study further expands the mutation spectrum of MSUD and contributes to prenatal molecular diagnosis of MSUD.

Indexed as

3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)AdultAmino Acids, Branched-ChainAsian PeopleDNA Mutational AnalysisFemaleHumansMaleMaple Syrup Urine DiseaseMiddle AgedMutationPathology, Molecular3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)Amino Acids, Branched-ChainBCKDHABCKDHBMaple syrup urine diseaseMutation

Identifiers

PMID29307017
OpenAlexW2781725579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.